Direct conversion of fibroblasts to functional neurons by defined factors.

Nature
Thomas VierbuchenMarius Wernig

Abstract

Cellular differentiation and lineage commitment are considered to be robust and irreversible processes during development. Recent work has shown that mouse and human fibroblasts can be reprogrammed to a pluripotent state with a combination of four transcription factors. This raised the question of whether transcription factors could directly induce other defined somatic cell fates, and not only an undifferentiated state. We hypothesized that combinatorial expression of neural-lineage-specific transcription factors could directly convert fibroblasts into neurons. Starting from a pool of nineteen candidate genes, we identified a combination of only three factors, Ascl1, Brn2 (also called Pou3f2) and Myt1l, that suffice to rapidly and efficiently convert mouse embryonic and postnatal fibroblasts into functional neurons in vitro. These induced neuronal (iN) cells express multiple neuron-specific proteins, generate action potentials and form functional synapses. Generation of iN cells from non-neural lineages could have important implications for studies of neural development, neurological disease modelling and regenerative medicine.

References

Aug 1, 1989·Trends in Genetics : TIG·H M Blau
Mar 7, 1996·Nature·K H CampbellI Wilmut
Jan 3, 2001·Nature Neuroscience·K L TuckerY A Barde
Aug 11, 2001·Science·T Jenuwein, C D Allis
Mar 5, 2002·Nature·Konrad Hochedlinger, Rudolf Jaenisch
Sep 3, 2002·Journal of Neuroscience Research·Marius WernigOliver Brüstle
May 28, 2004·Cell·Huafeng XieThomas Graf
Nov 13, 2004·Stem Cells·Jeong Tae Do, Hans R Schöler
Feb 15, 2005·Cell·Karen S ChristophersonBen A Barres
Oct 18, 2005·Current Opinion in Cell Biology·François Guillemot
Jan 10, 2006·Genesis : the Journal of Genetics and Development·Caroline BeardRudolf Jaenisch
May 1, 1952·Proceedings of the National Academy of Sciences of the United States of America·R Briggs, T J King
Nov 23, 2006·Journal of Neuroscience Methods·Anton MaximovThomas C Südhof
Feb 27, 2007·Cell·Bradley E BernsteinEric S Lander
Aug 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hao WuYi E Sun
Feb 26, 2008·Cell·Jose Silva, Austin Smith
Apr 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ru FengThomas Graf
Jul 3, 2008·Nature Biotechnology·Marius WernigRudolf Jaenisch
Aug 30, 2008·Nature·Qiao ZhouDouglas A Melton
Oct 23, 2008·Cell Stem Cell·Qiao Zhou, Douglas A Melton
Nov 10, 2009·Cell Stem Cell·Lars H BussmannThomas Graf

❮ Previous
Next ❯

Citations

Mar 3, 2012·EMBO Molecular Medicine·Paola BonfantiGiulio Cossu
Jan 1, 2013·Cellular and Molecular Life Sciences : CMLS·Kei Miyamoto, J B Gurdon
Jul 4, 2013·Der Nervenarzt·A HermannS Liebau
Jan 13, 2011·Archives of Toxicology·Anna M Wobus, Peter Löser
Apr 5, 2011·Seminars in Immunopathology·Suzanne Kadereit, Alan Trounson
Apr 25, 2012·Cell and Tissue Research·Sajjad Sisakhtnezhad, Maryam M Matin
Jun 15, 2012·Journal of Neural Transmission·Lezanne OoiGerald Münch
May 31, 2013·Journal of Neural Transmission·Andreas Hermann, Alexander Storch
Jun 11, 2011·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Satoshi GojoAkihiro Umezawa
Jul 17, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·H WangZ J Xu
Feb 22, 2011·Neurochemical Research·Jun Aruga, Katsuhiko Mikoshiba
Nov 10, 2011·Pharmaceutical Research·Amy BrockYuin-Han Loh
Jun 26, 2013·Journal of Molecular Neuroscience : MN·Akvilė JarmalavičiūtėAugustas Pivoriūnas
May 5, 2011·Molecular Neurobiology·Claire Perruisseau-CarrierColin P McGuckin
May 23, 2012·Molecular Neurobiology·Aisha Iman AbdullahTao Sun
Nov 10, 2010·Journal of Cardiovascular Translational Research·Steven J KattmanBlake D Anson
Oct 12, 2012·Journal of Cardiovascular Translational Research·Kohei Inagawa, Masaki Ieda
Jul 16, 2013·Journal of Cardiovascular Translational Research·Juan A Bernal
Mar 1, 2012·Archives of Pharmacal Research·Minjung SongSsang-Goo Cho
Nov 14, 2013·Archives of Pharmacal Research·Hyun-Ji ParkSeung-Woo Cho
Sep 9, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Arlene Y Chiu, Mahendra S Rao
Sep 9, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Olle Lindvall, Anders Björklund
May 7, 2011·Human Cell·Makoto OsonoiShinichi Abe
May 9, 2013·Ageing Research Reviews·Shauna H Yuan, Mason Shaner
Feb 18, 2014·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Ana Gabriela JimenezJoseph B Williams
Jan 10, 2013·Experimental Neurology·Fahad AliRoger A Barker
Oct 1, 2013·Genomics, Proteomics & Bioinformatics·Guangjun XiQi-Long Ying
May 28, 2013·Journal of Biotechnology·Binata Joddar, Yoshihiro Ito
Oct 17, 2013·Molecular and Cellular Neurosciences·Marilena RacitiAntonello Mallamaci

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence activated cell sorting
FACS
dissection

Software Mentioned

Clampfit

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.